08.10.2014 - IMI-TRAIN, an IMI/ENSO-funded broad education and training collaboration to support biomedical scientists and professionals, has officially been launched in a kick-off meeting kindly hosted by Roche in Basel on 18 September 2014.

IMI-TRAIN will form a platform for cross-project collaboration between the currently IMI-funded education and training projects EMTRAIN, Eu2P, PharmaTrain and SafeSciMET. The IMI-TRAIN groups will use synergies, share experiences, extend and re-shape their programmes and develop new competency profiles. IMI-TRAIN will pave the way towards an innovative, accessible and sustainable education and training environment in Europe.

Mike Hardman of AstraZeneca and EMTRAIN Coordinator comments on IMI-TRAIN’s launch:

“The start of any project is an important occasion, but none more so than the start of the first IMI collaborative project. The IMI-TRAIN official kick-off meeting on September 18th in Basel was an opportunity to hear what had already been achieved since July 1st, ensure a shared understanding of the project, and plan the next steps in more detail. Such is the commitment of all concerned that even an Air France strike was unable to prevent the meeting from going ahead as planned – we effectively used remote working technology. The project has already made significant achievements in all areas – which portends well for our continuing success. Now it’s full-steam ahead.”

IMI-TRAIN was awarded IMI/ENSO funding (Exploring New Scientific Opportunities) in March 2014 implying EFPIA co-funding. The EMTRAIN office will function as IMI-TRAIN’s project office.

For further information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. or call the EMTRAIN Project Office under +43 (0)1 40400 73748.